A Breakthrough in Tuberculosis
In 2010, an article was written detailing the severity of Tuberculosis
in the UK, with the Daily Telegraph labelling London as the ‘TB capitol of the
world’ with statistics highlighting the drastic rise in the number of diagnoses.
One study has accentuated the fact that
one fifth of cases of tuberculosis are resistant to at least one of major drug
treatments. Instances of tuberculosis have been falling in recent years but
England still maintains one of the highest rates in Europe. Yet, today we have
the achievements of researchers in both Oxford and Birmingham to recognise for
having a world first breakthrough in the incredibly serious disease.
First of all, tuberculosis itself is a bacterial infection which is
acquired through the inhalation of tiny droplets from sneezes or coughs of an
individual who is infected. When a person is healthy, their immune system is
able to kill the bacteria and the person won’t feel any symptoms, or the immune
system won’t be able to fight the bacteria directly but can prevent it from
spreading. Although, when tuberculosis takes full form (active TB), the part of
the body it attacks most prominently is the lungs which is known as pulmonary
TB, and this is the most contagious type of the infection. However, it is able
to impact any other part of the body to some degree also, including the abdomen
and nervous system. Some people may not display any symptoms yet the bacteria
will still be present in their body; this is referred to as latent TB and is
not contagious.
In a majority of cases, tuberculosis can be cured, done so with a course
of antibiotics taken over a six month period. Several forms of TB are resistant
to particular antibiotics, therefore a number of antibiotics must be taken to
combat this. The problem lies with diagnosing tuberculosis, as patients who are
suspected of having the infection have to wait up to a month to know if they
have it, which is ample time to for the infection to spread. Fortunately,
researchers are now able to employ genome sequencing (identifying the order of
nucleotides in a genome) in order to isolate various strains of the disease to know
which one a patient is infected with. As a result, patients can be diagnosed
and receive the correct medication within a week, significantly reducing
recovery time. The research is pertinent as it has allowed for a tighter grip
on the disease, serving to improve the lives of many individuals and their
families.
With 10 million people worldwide infected
with tuberculosis and 1.5 million people losing their lives as a result of it
each year, the achievements of the researchers is no small feat. Head of Oxford’s
Modernising Microbiology team Professor Derrick Crook commented on the
scientific advancement, stating he was proud of ‘the contribution this makes to
the prospects of better treatment of TB globally’, also recognising how the
breakthrough will not only be helpful in treating tuberculosis but will make it
possible to enhance the identification and treatment of other infectious diseases
and pathogens which are also resistant.
Please let us know your thoughts
on the breakthrough!
Written by Vicale Czan Alfanti
sources:
Very nice article!
ReplyDelete